Literature DB >> 25015029

Test-retest reliability of N400 event-related brain potential measures in a word-pair semantic priming paradigm in patients with schizophrenia.

Jenna E Boyd1, Iulia Patriciu2, Margaret C McKinnon3, Michael Kiang4.   

Abstract

The N400 event-related brain potential (ERP), a negative voltage deflection occurring approximately 400ms after onset of any meaningful stimulus, is reduced in amplitude when the stimulus is preceded by related context. Previous work has found this N400 semantic priming effect to be decreased in schizophrenia, suggesting impairment in using meaningful context to activate related concepts in semantic memory. Thus, N400 amplitude may be a useful biomarker of abnormal semantic processing and its response to treatment in schizophrenia. To help assess the validity of N400 amplitude as a longitudinal measure in schizophrenia, we evaluated its test-retest reliability. ERPs were recorded in sixteen schizophrenia patients who viewed prime words, each followed at 300- or 750-ms stimulus-onset asynchrony (SOA) by a target that was either a related or unrelated word, or nonword. Participants' task was to indicate whether or not the target was a real word. They were retested on the same procedure one week later. Test-retest reliability was assessed by calculating Pearson's r and intraclass correlation coefficients (ICCs) across timepoints for N400 amplitudes for related and unrelated targets, at each SOA. Consistent with previous results, there were no significant differences between patients' N400 amplitudes for related and unrelated targets, at any SOA/timepoint combination. Pearson's r and ICCs for N400 amplitudes at Fz across timepoints were significant for both target types at each SOA (ranges: r 0.52-0.64, ICC 0.52-0.63; all p<.04). The results suggest potential utility of N400 amplitude as a longitudinal neurophysiological biomarker of semantic processing abnormalities in schizophrenia.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognition; Event-related potentials; Neurophysiology; Schizophrenia; Semantics; Test–retest reliability

Mesh:

Year:  2014        PMID: 25015029     DOI: 10.1016/j.schres.2014.06.018

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  6 in total

1.  An incongruent reality: the N400 in relation to psychosis and recovery.

Authors:  Felicia Jackson; Dan Foti; Roman Kotov; Greg Perlman; Daniel H Mathalon; Greg Hajcak Proudfit
Journal:  Schizophr Res       Date:  2014-10-22       Impact factor: 4.939

2.  Validity of an eyetracking method for capturing auditory-visual cross-format semantic priming.

Authors:  Javad Anjum; Brooke Hallowell
Journal:  J Clin Exp Neuropsychol       Date:  2019-02-06       Impact factor: 2.475

3.  Event-related potentials elicited by the Deutsch "high-low" word illusion in the patients with first-episode schizophrenia with auditory hallucinations.

Authors:  You Xu; Hao Chai; Bingren Zhang; Qianqian Gao; Hongying Fan; Leilei Zheng; Hongjing Mao; Yonghua Zhang; Wei Wang
Journal:  BMC Psychiatry       Date:  2016-02-18       Impact factor: 3.630

4.  Abnormal N400 Semantic Priming Effect May Reflect Psychopathological Processes in Schizophrenia: A Twin Study.

Authors:  Anuradha Sharma; Heinrich Sauer; Holger Hill; Claudia Kaufmann; Stephan Bender; Matthias Weisbrod
Journal:  Schizophr Res Treatment       Date:  2017-08-28

5.  Effects of Repetitive Transcranial Magnetic Stimulation Treatment on Event-Related Potentials in Schizophrenia.

Authors:  Xiao-Dong Lin; Xing-Shi Chen; Ce Chen; Li-Jun Zhang; Zuo-Liang Xie; Zi-Ye Huang; Guang-Dong Chen; Wan-Tao Ding; Zhi-Guang Lin; Ming-Dao Zhang; Chong Chen; Rong-Qin Wu
Journal:  Chin Med J (Engl)       Date:  2018-02-05       Impact factor: 2.628

6.  Effects of Risperidone and Paliperidone on Brain-Derived Neurotrophic Factor and N400 in First-Episode Schizophrenia.

Authors:  Rong-Qin Wu; Chong-Guang Lin; Wei Zhang; Xiao-Dong Lin; Xing-Shi Chen; Ce Chen; Li-Jun Zhang; Zi-Ye Huang; Guang-Dong Chen; Da-Li Xu; Zhi-Guang Lin; Ming-Dao Zhang
Journal:  Chin Med J (Engl)       Date:  2018-10-05       Impact factor: 2.628

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.